215 related articles for article (PubMed ID: 32862421)
21. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
[TBL] [Abstract][Full Text] [Related]
22. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
[TBL] [Abstract][Full Text] [Related]
23. Prenatal tobacco smoke exposure and neurological impairment at 10 years of age among children born extremely preterm: a prospective cohort.
Venkatesh KK; Leviton A; Fichorova RN; Joseph RM; Douglass LM; Frazier JA; Kuban K; Santos HP; Fry RC; O'Shea TM
BJOG; 2021 Sep; 128(10):1586-1597. PubMed ID: 33682301
[TBL] [Abstract][Full Text] [Related]
24. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
[TBL] [Abstract][Full Text] [Related]
25. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation.
Venkatesh KK; Leviton A; Hecht JL; Joseph RM; Douglass LM; Frazier JA; Daniels JL; Fry RC; O'Shea TM; Kuban KCK
Am J Obstet Gynecol; 2020 Nov; 223(5):745.e1-745.e10. PubMed ID: 32387324
[TBL] [Abstract][Full Text] [Related]
26. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
Costantine MM; Weiner SJ;
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
[TBL] [Abstract][Full Text] [Related]
27. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years.
Schendel DE; Berg CJ; Yeargin-Allsopp M; Boyle CA; Decoufle P
JAMA; 1996 Dec; 276(22):1805-10. PubMed ID: 8946900
[TBL] [Abstract][Full Text] [Related]
28. Working to improve survival and health for babies born very preterm: the WISH project protocol.
Crowther CA; Middleton PF; Bain E; Ashwood P; Bubner T; Flenady V; Morris J; McIntyre S;
BMC Pregnancy Childbirth; 2013 Dec; 13():239. PubMed ID: 24354790
[TBL] [Abstract][Full Text] [Related]
29. Mode of delivery at periviability and early childhood neurodevelopment.
Običan SG; Small A; Smith D; Levin H; Drassinower D; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2015 Oct; 213(4):578.e1-4. PubMed ID: 26116869
[TBL] [Abstract][Full Text] [Related]
30. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
31. Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers.
Bozkurt O; Eras Z; Canpolat FE; Oguz SS; Uras N; Dilmen U
J Matern Fetal Neonatal Med; 2016; 29(7):1101-4. PubMed ID: 25893546
[TBL] [Abstract][Full Text] [Related]
32. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
33. Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
Gentle SJ; Carlo WA; Tan S; Gargano M; Ambalavanan N; Chawla S; Bell EF; Bann CM; Hintz SR; Heyne RJ; Tita A; Higgins RD;
Obstet Gynecol; 2020 Jun; 135(6):1377-1386. PubMed ID: 32459430
[TBL] [Abstract][Full Text] [Related]
34. Differential Morbidity in Preterm Small versus Appropriate for Gestational Age: Perhaps Unverifiable.
Marrs CC; Mendez-Figueroa H; Hammad IA; Chauhan SP
Am J Perinatol; 2015 Nov; 32(13):1251-6. PubMed ID: 26023905
[TBL] [Abstract][Full Text] [Related]
35. Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
Chollat C; Bertrand E; Petit-Ledo A; de Vansay C; Voisin C; Dabaj I; Gillibert A; Marret S;
J Pediatr; 2021 Oct; 237():183-189.e6. PubMed ID: 34144033
[TBL] [Abstract][Full Text] [Related]
36. The feasibility of a randomized clinical perinatal trial: maternal magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hauth JC; Nelson KG; Goldenberg RL
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):701-5. PubMed ID: 8828437
[TBL] [Abstract][Full Text] [Related]
37. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.
Metz TD; Allshouse AA; Hogue CJ; Goldenberg RL; Dudley DJ; Varner MW; Conway DL; Saade GR; Silver RM
Am J Obstet Gynecol; 2017 Oct; 217(4):478.e1-478.e8. PubMed ID: 28578174
[TBL] [Abstract][Full Text] [Related]
38. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis.
Cahill AG; Odibo AO; Stout MJ; Grobman WA; Macones GA; Caughey AB
Am J Obstet Gynecol; 2011 Dec; 205(6):542.e1-7. PubMed ID: 22000669
[TBL] [Abstract][Full Text] [Related]
39. Impact of obstetric factors on outcome of extremely preterm births in Sweden: prospective population-based observational study (EXPRESS).
Källén K; Serenius F; Westgren M; Maršál K;
Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1203-14. PubMed ID: 26249263
[TBL] [Abstract][Full Text] [Related]
40. Visual impairment in children born prematurely from 1972 through 1989.
Rudanko SL; Fellman V; Laatikainen L
Ophthalmology; 2003 Aug; 110(8):1639-45. PubMed ID: 12917186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
